A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Colleagues Applaud Unanimous Senate Passage of Glioblastoma Resolution
Washington, D.C. — U.S. Senators Marco Rubio (R-FL), Lindsey Graham (R-SC), Kyrsten Sinema (D-AZ), Mark Kelly (D-AZ), Elizabeth Warren (D-MA), Ed Markey (D-MA), Chris Coons (D-DE), and Raphael Warnock (D-GA) applauded the unanimous Senate passage of their resolution designating July 21, 2021 as Glioblastoma Awareness Day.
A companion resolution was introduced in the U.S. House of Representatives by Representatives Brian Mast (R-FL), Mike Gallagher (R-WI), Jan Schakowsky (D-IL), and Jim Langevin (D-RI).
Rubio has championed the fight against cancer. On May 3, 2021, he introduced the Gabriella Miller Kids First Research Act 2.0 that would provide a new source of funding for the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program (Kids First) by redirecting penalties collected from pharmaceutical, cosmetic, supplement, and medical device companies that break the law to pediatric and childhood cancer research.
On March 11, 2021, Rubio reintroduced the Women and Lung Cancer Research and Preventative Services Act to encourage more research into the prevention and treatment of lung cancer in women, particularly those who have never smoked, and require federal agencies to evaluate and report their findings to Congress. This legislation was first introduced in January 2018.
In August 2020, his bipartisan Research to Accelerate Cures and Equity (RACE) for Children Act went into effect. The law provides children battling cancer with more innovative and promising treatment options.
As a member of the Senate Committee on Appropriations, Rubio has led the Senate in funding the fight against cancer. In the FY 2021 appropriations bill, Rubio secured:
- Pediatric cancer language, including Molecular Analysis for Therapy Choice (MATCH), language to enable researchers to map the genetic makeup of pediatric cancer to pave the way for new therapies
- An increase of $119.4 million in funding for the National Cancer Institute ($6.56 billion total)
- An increase of $5 million for the Centers for Disease Control and Prevention’s Division of Cancer Prevention and Control ($386 million total)
The resolution:
- Designates July 21, 2021 as Glioblastoma Awareness Day
- Encourages increased public awareness of glioblastoma
- Honors the individuals who have lost their lives to glioblastoma or are currently living with it
- Supports efforts to develop better treatments for glioblastoma that will improve the long term prognosis and quality of life of individuals diagnosed with the disease
- Expresses its support for the individuals who are battling brain tumors, as well as the families, friends, and caregivers of those individuals
- Urges a collaborative approach to brain tumor research, which is a promising means of advancing the understanding and treatment of glioblastoma
- Encourages continued investment in glioblastoma research and treatments, including through the Glioblastoma Therapeutics Network and other existing brain tumor research resources